SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2ipj'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IHI_A_IU5A326_1
(3-ALPHA-HYDROXYSTERO
ID DEHYDROGENASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 10 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.45A 1ihiA-2ipjA:
55.3
1ihiA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IHI_A_IU5A326_1
(3-ALPHA-HYDROXYSTERO
ID DEHYDROGENASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
9 / 10 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
GLU A 224
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.57A 1ihiA-2ipjA:
55.3
1ihiA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1IHI_B_IU5B327_1
(3-ALPHA-HYDROXYSTERO
ID DEHYDROGENASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 9 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
GLU A 224
TRP A 227
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
None
FFA  A 325 (-3.8A)
0.61A 1ihiB-2ipjA:
55.2
1ihiB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1J96_A_TESA903_1
(3ALPHA-HYDROXYSTEROI
D DEHYDROGENASE TYPE
3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 6 TRP A  86
VAL A 128
ILE A 129
TRP A 227
LEU A 306
None
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.56A 1j96A-2ipjA:
55.9
1j96A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1J96_B_TESB904_1
(3ALPHA-HYDROXYSTEROI
D DEHYDROGENASE TYPE
3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 7 VAL A 128
ILE A 129
HIS A 222
GLU A 224
TRP A 227
LEU A 306
None
None
NAP  A   1 ( 4.8A)
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.81A 1j96B-2ipjA:
55.5
1j96B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MRQ_A_STRA501_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 11 TYR A  55
ILE A 129
HIS A 222
GLU A 224
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
NAP  A   1 ( 4.8A)
None
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.80A 1mrqA-2ipjA:
55.2
1mrqA-2ipjA:
97.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MRQ_A_STRA501_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 11 TYR A  55
VAL A 128
ILE A 129
HIS A 222
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.65A 1mrqA-2ipjA:
55.2
1mrqA-2ipjA:
97.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1MRQ_A_STRA501_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 11 TYR A  55
VAL A 128
ILE A 129
HIS A 222
TRP A 227
FFA  A 325 ( 4.3A)
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
0.95A 1mrqA-2ipjA:
55.2
1mrqA-2ipjA:
97.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1NT2_A_SAMA301_0
(FIBRILLARIN-LIKE
PRE-RRNA PROCESSING
PROTEIN)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 GLY A  22
ALA A  24
ALA A  41
ASP A  50
ILE A  49
NAP  A   1 (-3.3A)
NAP  A   1 (-3.3A)
None
NAP  A   1 (-3.7A)
None
0.93A 1nt2A-2ipjA:
undetectable
1nt2A-2ipjA:
21.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1Q13_A_TESA501_1
(PROSTAGLANDIN-E2
9-REDUCTASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 6 TYR A  55
HIS A 117
GLU A 224
PRO A 226
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
None
0.85A 1q13A-2ipjA:
52.1
1q13A-2ipjA:
78.02
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1S2A_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TRP A  86
HIS A 117
GLU A 192
TYR A 216
SER A 217
None
FFA  A 325 ( 3.8A)
None
NAP  A   1 (-3.2A)
NAP  A   1 (-2.8A)
0.28A 1s2aA-2ipjA:
51.3
1s2aA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1S2A_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TRP A  86
HIS A 117
GLU A 192
TYR A 216
TRP A 227
None
FFA  A 325 ( 3.8A)
None
NAP  A   1 (-3.2A)
FFA  A 325 (-3.8A)
1.49A 1s2aA-2ipjA:
51.3
1s2aA-2ipjA:
86.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UPF_B_URFB999_1
(URACIL
PHOSPHORIBOSYLTRANSF
ERASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 7 ALA A 245
ILE A 255
ILE A 296
ASP A 238
None
0.92A 1upfB-2ipjA:
undetectable
1upfB-2ipjA:
22.77
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1XJB_A_ACTA1002_0
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 4 TYR A   5
PRO A  17
HIS A  47
PHE A 284
BME  A 326 (-4.0A)
EDO  A 330 (-4.6A)
None
EDO  A 330 (-4.7A)
0.07A 1xjbA-2ipjA:
56.9
1xjbA-2ipjA:
98.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QMM_A_SAMA301_0
(UPF0217 PROTEIN
AF_1056)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 LEU A  85
GLY A 164
SER A  87
SER A 121
LEU A 144
None
1.19A 2qmmA-2ipjA:
undetectable
2qmmA-2ipjA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3A3Y_A_OBNA6000_1
(NA, K-ATPASE ALPHA
SUBUNIT)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 10 PHE A  80
VAL A  38
ALA A  41
LEU A 268
THR A  23
None
None
None
NAP  A   1 (-4.2A)
None
1.17A 3a3yA-2ipjA:
undetectable
3a3yA-2ipjA:
15.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BWC_A_SAMA501_0
(SPERMIDINE SYNTHASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 HIS A 117
ILE A 163
GLY A 164
VAL A 214
ASP A  12
FFA  A 325 ( 3.8A)
None
None
None
None
1.02A 3bwcA-2ipjA:
undetectable
3bwcA-2ipjA:
24.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_D_TRPD1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 GLY A  22
HIS A  48
ASP A  50
VAL A  61
VAL A  38
NAP  A   1 (-3.3A)
None
NAP  A   1 (-3.7A)
None
None
1.47A 3fhjD-2ipjA:
undetectable
3fhjD-2ipjA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FHJ_F_TRPF1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 GLY A  22
HIS A  48
ASP A  50
VAL A  61
VAL A  38
NAP  A   1 (-3.3A)
None
NAP  A   1 (-3.7A)
None
None
1.47A 3fhjF-2ipjA:
undetectable
3fhjF-2ipjA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FI0_J_TRPJ1001_0
(TRYPTOPHANYL-TRNA
SYNTHETASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 GLY A  22
HIS A  48
ASP A  50
VAL A  61
VAL A  38
NAP  A   1 (-3.3A)
None
NAP  A   1 (-3.7A)
None
None
1.45A 3fi0J-2ipjA:
undetectable
3fi0J-2ipjA:
22.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ID6_C_SAMC301_0
(FIBRILLARIN-LIKE
RRNA/TRNA
2'-O-METHYLTRANSFERA
SE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 GLY A  22
ALA A  24
ALA A  41
ASP A  50
ILE A  49
NAP  A   1 (-3.3A)
NAP  A   1 (-3.3A)
None
NAP  A   1 (-3.7A)
None
0.88A 3id6C-2ipjA:
undetectable
3id6C-2ipjA:
18.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R43_A_ID8A332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TYR A 216
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
0.12A 3r43A-2ipjA:
51.8
3r43A-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R58_A_NPSA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 10 TYR A  55
HIS A 117
ASN A 167
TYR A 216
PRO A 318
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
None
0.30A 3r58A-2ipjA:
50.5
3r58A-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R6I_A_JMSA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TYR A 216
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
0.18A 3r6iA-2ipjA:
50.4
3r6iA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R8G_A_IZPA409_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 TYR A  55
HIS A 117
ASN A 167
TYR A 216
PRO A 318
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
None
0.32A 3r8gA-2ipjA:
50.5
3r8gA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3R94_A_FLRA332_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TYR A  55
HIS A 117
ASN A 167
TYR A 216
PRO A 318
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
None
0.37A 3r94A-2ipjA:
50.2
3r94A-2ipjA:
86.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RC0_A_SAMA484_0
(N-LYSINE
METHYLTRANSFERASE
SETD6)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 11 GLY A  62
ALA A  24
LEU A  40
TYR A 272
PHE A  21
None
NAP  A   1 (-3.3A)
None
None
None
1.18A 3rc0A-2ipjA:
undetectable
3rc0A-2ipjA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RC0_B_SAMB480_0
(N-LYSINE
METHYLTRANSFERASE
SETD6)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 GLY A  62
ALA A  24
LEU A  40
TYR A 272
PHE A  21
None
NAP  A   1 (-3.3A)
None
None
None
1.17A 3rc0B-2ipjA:
undetectable
3rc0B-2ipjA:
23.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RUK_A_AERA601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 ALA A 269
LEU A 261
ALA A 253
THR A 251
VAL A 283
NAP  A   1 ( 4.8A)
None
NAP  A   1 (-3.5A)
None
None
0.92A 3rukA-2ipjA:
undetectable
3rukA-2ipjA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RUK_B_AERB601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 ALA A 269
LEU A 261
ALA A 253
THR A 251
VAL A 283
NAP  A   1 ( 4.8A)
None
NAP  A   1 (-3.5A)
None
None
0.91A 3rukB-2ipjA:
undetectable
3rukB-2ipjA:
22.71
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UG8_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 12 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TYR A 216
SER A 217
SER A 221
PRO A 318
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
NAP  A   1 (-2.8A)
None
None
0.46A 3ug8A-2ipjA:
50.3
3ug8A-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UGR_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 HIS A 117
TYR A 216
SER A 217
SER A 221
PHE A 311
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.2A)
NAP  A   1 (-2.8A)
None
None
0.82A 3ugrA-2ipjA:
49.9
3ugrA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UGR_A_IMNA2001_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 TRP A  86
HIS A 117
TYR A 216
SER A 217
SER A 221
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.2A)
NAP  A   1 (-2.8A)
None
0.29A 3ugrA-2ipjA:
49.9
3ugrA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3UGR_A_IMNA2001_2
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 7 TYR A  55
ASN A 167
GLU A 192
TYR A 305
PRO A 318
FFA  A 325 ( 4.3A)
NAP  A   1 (-3.1A)
None
None
None
0.54A 3ugrA-2ipjA:
49.9
3ugrA-2ipjA:
86.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DTZ_A_LDPA501_1
(CYTOCHROME P450 BM3
VARIANT 8C8)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 6 ALA A 218
ALA A 253
PRO A 252
LEU A 235
None
NAP  A   1 (-3.5A)
BME  A 327 (-4.5A)
None
0.92A 4dtzA-2ipjA:
undetectable
4dtzA-2ipjA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DTZ_B_LDPB501_1
(CYTOCHROME P450 BM3
VARIANT 8C8)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 6 ALA A 218
ALA A 253
PRO A 252
LEU A 235
None
NAP  A   1 (-3.5A)
BME  A 327 (-4.5A)
None
0.93A 4dtzB-2ipjA:
undetectable
4dtzB-2ipjA:
21.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DU2_A_LDPA501_1
(CYTOCHROME P450 BM3
VARIANT B7)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 7 ALA A 218
ALA A 253
PRO A 252
LEU A 235
None
NAP  A   1 (-3.5A)
BME  A 327 (-4.5A)
None
0.90A 4du2A-2ipjA:
undetectable
4du2A-2ipjA:
21.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DU2_B_LDPB501_1
(CYTOCHROME P450 BM3
VARIANT B7)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 7 ALA A 218
ALA A 253
PRO A 252
LEU A 235
None
NAP  A   1 (-3.5A)
BME  A 327 (-4.5A)
None
0.92A 4du2B-2ipjA:
undetectable
4du2B-2ipjA:
21.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ1_A_NPSA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 9 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.65A 4jq1A-2ipjA:
55.5
4jq1A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ1_B_NPSB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 8 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.49A 4jq1B-2ipjA:
54.5
4jq1B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ1_B_NPSB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 8 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.46A 4jq1B-2ipjA:
54.5
4jq1B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ2_A_SUZA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 10 VAL A  54
TYR A  55
TRP A  86
HIS A 117
ILE A 129
HIS A 222
GLU A 224
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
NAP  A   1 ( 4.8A)
None
FFA  A 325 (-4.8A)
0.57A 4jq2A-2ipjA:
55.7
4jq2A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ2_A_SUZA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 10 VAL A  54
TYR A  55
TRP A  86
HIS A 117
ILE A 129
HIS A 222
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.54A 4jq2A-2ipjA:
55.7
4jq2A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_A_IMNA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 10 VAL A  54
TYR A  55
HIS A 117
VAL A 128
GLU A 224
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
1.02A 4jq4A-2ipjA:
55.4
4jq4A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_A_IMNA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 10 VAL A  54
TYR A  55
HIS A 117
VAL A 128
TYR A 216
GLU A 224
TRP A 227
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
NAP  A   1 (-3.2A)
None
FFA  A 325 (-3.8A)
0.83A 4jq4A-2ipjA:
55.4
4jq4A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_A_IMNA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 10 VAL A  54
TYR A  55
HIS A 117
VAL A 128
TYR A 216
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
NAP  A   1 (-3.2A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.75A 4jq4A-2ipjA:
55.4
4jq4A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_B_IMNB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 10 TYR A  55
HIS A 117
VAL A 128
ASN A 167
TRP A 227
LEU A 308
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
NAP  A   1 (-3.1A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.86A 4jq4B-2ipjA:
54.1
4jq4B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_B_IMNB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 10 TYR A  55
HIS A 117
VAL A 128
ILE A 129
ASN A 167
TYR A 216
LEU A 306
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
None
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
FFA  A 325 (-4.8A)
0.45A 4jq4B-2ipjA:
54.1
4jq4B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQ4_B_IMNB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 10 TYR A  55
HIS A 117
VAL A 128
ILE A 129
ASN A 167
TYR A 216
TRP A 227
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
None
None
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
FFA  A 325 (-3.8A)
0.43A 4jq4B-2ipjA:
54.1
4jq4B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQA_A_ID8A401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.41A 4jqaA-2ipjA:
55.6
4jqaA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQA_A_ID8A401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 9 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.36A 4jqaA-2ipjA:
55.6
4jqaA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQA_B_ID8B401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.46A 4jqaB-2ipjA:
55.1
4jqaB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JQA_B_ID8B401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 9 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.40A 4jqaB-2ipjA:
55.1
4jqaB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTQ_A_FLPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
9 / 10 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.17A 4jtqA-2ipjA:
55.8
4jtqA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTQ_B_FLPB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.38A 4jtqB-2ipjA:
55.5
4jtqB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTQ_B_FLPB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 9 VAL A  54
TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.23A 4jtqB-2ipjA:
55.5
4jtqB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_A_IBPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 8 VAL A  54
TYR A  55
HIS A 117
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
1.48A 4jtrA-2ipjA:
55.8
4jtrA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_A_IBPA401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 8 VAL A  54
TYR A  55
TRP A  86
HIS A 117
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.44A 4jtrA-2ipjA:
55.8
4jtrA-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4JTR_B_IZPB401_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 6 VAL A  54
TYR A  55
TRP A  86
HIS A 117
TRP A 227
FFA  A 325 (-4.8A)
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
FFA  A 325 (-3.8A)
0.18A 4jtrB-2ipjA:
55.2
4jtrB-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1W_A_STRA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 7 VAL A 128
ILE A 129
HIS A 222
TRP A 227
LEU A 306
LEU A 308
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.72A 4l1wA-2ipjA:
56.1
4l1wA-2ipjA:
98.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1W_B_STRB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 6 VAL A  54
VAL A 128
ILE A 129
TRP A 227
LEU A 308
FFA  A 325 (-4.8A)
None
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.42A 4l1wB-2ipjA:
56.2
4l1wB-2ipjA:
98.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1X_A_STRA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 8 TYR A  55
VAL A 128
HIS A 222
LEU A 308
FFA  A 325 ( 4.3A)
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-4.5A)
0.47A 4l1xA-2ipjA:
56.2
4l1xA-2ipjA:
98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1X_A_STRA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 8 TYR A  55
VAL A 128
HIS A 222
TRP A 227
FFA  A 325 ( 4.3A)
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
0.76A 4l1xA-2ipjA:
56.2
4l1xA-2ipjA:
98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1X_B_STRB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 9 TYR A  55
VAL A 128
ILE A 129
HIS A 222
GLU A 224
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
None
NAP  A   1 ( 4.8A)
None
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.82A 4l1xB-2ipjA:
56.3
4l1xB-2ipjA:
98.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4L1X_B_STRB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
7 / 9 TYR A  55
VAL A 128
ILE A 129
HIS A 222
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.83A 4l1xB-2ipjA:
56.3
4l1xB-2ipjA:
98.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4LZR_A_LOCA201_1
(BROMODOMAIN-CONTAINI
NG PROTEIN 4)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 8 LEU A 108
LEU A 106
ASP A  50
ILE A  49
None
None
NAP  A   1 (-3.7A)
None
0.91A 4lzrA-2ipjA:
undetectable
4lzrA-2ipjA:
18.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKV_B_AERB601_1
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 12 ALA A 269
LEU A 261
ALA A 253
THR A 251
VAL A 283
NAP  A   1 ( 4.8A)
None
NAP  A   1 (-3.5A)
None
None
0.97A 4nkvB-2ipjA:
undetectable
4nkvB-2ipjA:
22.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XO7_A_ASDA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 7 VAL A 128
HIS A 222
TRP A 227
LEU A 306
LEU A 308
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.88A 4xo7A-2ipjA:
56.0
4xo7A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XO7_A_ASDA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 7 VAL A 128
ILE A 129
HIS A 222
TRP A 227
LEU A 308
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.5A)
0.82A 4xo7A-2ipjA:
56.0
4xo7A-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4XO7_B_ASDB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 7 VAL A  54
TRP A  86
ILE A 129
HIS A 222
TRP A 227
LEU A 306
FFA  A 325 (-4.8A)
None
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
0.83A 4xo7B-2ipjA:
56.3
4xo7B-2ipjA:
99.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVP_A_GBMA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 11 TYR A  55
HIS A 222
GLU A 224
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
NAP  A   1 ( 4.8A)
None
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.81A 4yvpA-2ipjA:
54.4
4yvpA-2ipjA:
97.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVP_A_GBMA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
8 / 11 TYR A  55
TRP A  86
HIS A 117
ILE A 129
HIS A 222
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.59A 4yvpA-2ipjA:
54.4
4yvpA-2ipjA:
97.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVP_B_GBMB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C1)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
10 / 12 TYR A  55
TRP A  86
HIS A 117
VAL A 128
ILE A 129
ASN A 167
HIS A 222
TRP A 227
LEU A 306
LEU A 308
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
None
None
NAP  A   1 (-3.1A)
NAP  A   1 ( 4.8A)
FFA  A 325 (-3.8A)
FFA  A 325 (-4.8A)
FFA  A 325 (-4.5A)
0.62A 4yvpB-2ipjA:
54.7
4yvpB-2ipjA:
97.51
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4YVV_A_GBMA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
6 / 9 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TYR A 216
TRP A 227
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
NAP  A   1 (-3.2A)
FFA  A 325 (-3.8A)
0.47A 4yvvA-2ipjA:
52.2
4yvvA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZFC_A_GCZA402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TRP A 227
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
FFA  A 325 (-3.8A)
0.92A 4zfcA-2ipjA:
52.3
4zfcA-2ipjA:
86.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ZFC_B_GCZB402_1
(ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C3)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
5 / 9 TYR A  55
TRP A  86
HIS A 117
ASN A 167
TRP A 227
FFA  A 325 ( 4.3A)
None
FFA  A 325 ( 3.8A)
NAP  A   1 (-3.1A)
FFA  A 325 (-3.8A)
0.97A 4zfcB-2ipjA:
52.7
4zfcB-2ipjA:
86.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HS6_A_J3ZA302_1
(17-BETA-HYDROXYSTERO
ID DEHYDROGENASE 14)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
4 / 8 TYR A  81
LEU A 103
LEU A  99
MET A 151
None
1.17A 5hs6A-2ipjA:
undetectable
5hs6A-2ipjA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5U63_A_ACTA406_0
(THIOREDOXIN
REDUCTASE)
2ipj ALDO-KETO REDUCTASE
FAMILY 1 MEMBER C2

(Homo
sapiens)
3 / 3 HIS A 194
SER A 217
ARG A 223
None
NAP  A   1 (-2.8A)
None
0.85A 5u63A-2ipjA:
undetectable
5u63A-2ipjA:
22.91